Katherine Redmond-Larimer
Family · San Andreas, CANPI 1831468255
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,632 of the $2,117 with a category attached, or 77.1%. It is spread thinly across 36 manufacturers, the largest accounting for just 18.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $865 and has fallen 81.6% since, to $159 in 2025.
Across 82 payments — averaging $25.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Seagen Inc.$401
- Novartis$243
- Gilead$124
- Sanofi-aventis U.S. LLC$100
- Amgen$90
- Servier Pharmaceuticals LLC$89
- plus $1K from 30 others
What the payments were for
- Food & beverage$1,63277%
- Education$48523%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Seagen Inc. | 13 | $401 |
| Novartis | 13 | $243 |
| Gilead(2 entities) | 2 | $124 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| Amgen | 3 | $90 |
| Servier Pharmaceuticals LLC | 4 | $89 |
| Johnson & Johnson | 3 | $86 |
| AVEO Pharmaceuticals, Inc. | 1 | $85 |
| Pfizer | 3 | $72 |
| E.r. Squibb & Sons, L.L.C. | 3 | $60 |
| Sanofi | 3 | $55 |
| Collegium Pharmaceutical, Inc. | 1 | $54 |
| Lilly USA, LLC | 2 | $46 |
| Karyopharm Therapeutics Inc. | 2 | $46 |
| GRT US Holding, Inc. | 1 | $45 |
| Merck | 2 | $44 |
| Regeneron Healthcare Solutions, Inc. | 2 | $40 |
| Bristol Myers Squibb | 2 | $38 |
| EMD Serono, Inc. | 2 | $36 |
| Beigene USA, Inc. | 2 | $33 |
| Organon | 1 | $32 |
| Array Biopharma Inc | 1 | $31 |
| Blueprint Medicines Corporation | 1 | $25 |
| Myovant Sciences Inc. | 1 | $24 |
| AstraZeneca | 1 | $24 |
| Impel Pharmaceuticals Inc. | 1 | $23 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $22 |
| GE HealthCare | 1 | $20 |
| Sobi, Inc | 1 | $20 |
| Eisai Inc. | 1 | $19 |
| Taiho Oncology, Inc. | 1 | $17 |
| Heron Therapeutics, Inc. | 1 | $17 |
| Clovis Oncology, Inc. | 2 | $16 |
| Boehringer Ingelheim | 1 | $15 |
| Astellas Pharma US Inc | 1 | $14 |
| Exelixis Inc. | 1 | $13 |
How this compares
$2,117 in reported general payments places this provider in the 85th percentile of 10,634 family providers in California.
Other family in San Andreas
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Erin DwyerSan Diego$189K
- Phyllis CasonLos Angeles$187K
- Gabriel SchwartzSan Francisco$166K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.